U.S. Entertainment Stock News

Readers hoping to buy Eagle Financial Services, Inc. ( NASDAQ:EFSI ) for its dividend will need to make their move...

Cracker Barrel Old Country Store has more than doubled year to date, yet the stock still screens as expensive on Simply Wall St’s valuation checks, which raises a clear question about how much of the recent optimism is already in the price. The stock is up 110.6% year to date, which suggests expectations have reset sharply higher after a difficult few years for shareholders. Recent moves to sell Maple Street Biscuit Company, complete a sale and leaseback of some stores, and refresh...

Argan stock has delivered an extremely strong run over the past three years, yet on the current checks it does not screen as a clear bargain and recent price weakness raises questions about how much valuation support remains. Argan has returned very roughly 12x over three years, which is a very large gain and leaves current holders asking how much of the story is already reflected in the share price. The key support for the valuation can come from the company continuing to convert its...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Revvity’s share price has risen over the past year, yet its longer term record is weaker and the valuation tools do not quite line up. The Discounted Cash Flow (DCF) intrinsic value estimate points to a discount to current pricing, while earnings based multiples signal a richer valuation. Over 5 years, Revvity’s shareholders have seen the stock decline 38.6%, which makes the current valuation more sensitive to how the next phase of the business plays out. Expectations for future cash flow...

Schrödinger (SDGR) has put its AI ambitions in focus after launching early access to Bunsen, an agentic AI co-scientist designed to support molecular discovery workflows using its physics-based simulation platform. See our latest analysis for Schrödinger. The launch of Bunsen comes at a time when Schrödinger's share price has been volatile. A 26.42% 90-day share price return contrasts with a 13.05% decline over 30 days and a 26.99% decline in total shareholder return over the past year, which...

We'd be surprised if First Community Corporation ( NASDAQ:FCCO ) shareholders haven't noticed that the Director of...

Cheesecake Factory (NasdaqGS:CAKE) reported record quarterly revenue above US$1b, with decade high margins. The company launched a new cheesecake flavor tied to a National Cheesecake Day campaign supporting Feeding America. The news combines a major sales milestone with a charitable initiative that connects brand visibility and social impact. Cheesecake Factory operates a large casual dining chain centered on full service restaurants and an extensive dessert offering. This mix positions...

AI driven hiring tools, virtual interviews and tighter rules around “social value” are reshaping how companies recruit, especially in the UK. That shift can help some stocks exposed to this trend and hurt others, depending on how they earn revenue and manage compliance pressure. If you care about where recruitment and workforce tech might fit in your portfolio, this screener offers a focused way to think about it. The rest of this article breaks down three stocks linked to these developments,...

Sanara MedTech Inc. ( NASDAQ:SMTI ), might not be a large cap stock, but it saw a significant share price rise of 68...

Upcoming earnings call puts Medical Properties Trust in focus Medical Properties Trust (MPT) has scheduled a conference call and webcast on August 10, 2026, to discuss its second quarter 2026 results, with a press release set for before the market opens. See our latest analysis for Medical Properties Trust. At a last close of US$4.75, Medical Properties Trust’s recent share price return has been mixed, with a 30 day share price gain of 2.81% but a year to date share price decline of 6.5%. The...

Energy stocks are back in focus after Shell reported Q2 profits of $9.84b, with earnings more than doubling year over year alongside a sharp jump in oil prices. The conflict involving the US, Israel and Iran has disrupted crude and LNG flows through the Strait of Hormuz, and Brent crude prices have swung from around $73 to peaks above $120 a barrel. That kind of volatility can reshape risks and opportunities across the sector. This article looks at 3 large Energy sector stocks exposed to...

Gossamer Bio recently reported that, following a Pre-NDA Type B meeting with the FDA, it is preparing a September 2026 NDA submission for seralutinib in pulmonary arterial hypertension, while also reacquiring worldwide rights to the drug and disclosing approximately US$57,000,000 in cash, cash equivalents and marketable securities as of June 30, 2026. An interesting angle is that the FDA flagged the strength of PROSERA’s results as review issues rather than filing issues, allowing Gossamer...

Dividend increase puts Hess Midstream’s cash returns in focus Hess Midstream (HESM) has drawn fresh attention after its board declared a quarterly cash distribution of $0.7888 per Class A share for the June 30, 2026 quarter, an increase of $0.0096 from the prior quarter. The payout is scheduled for August 14, 2026, to Class A shareholders of record on August 6, 2026. This gives income focused investors a clear date to watch and a concrete cash figure to evaluate. See our latest analysis for...

In the past week, Robert Half Inc. reported second-quarter 2026 results showing net income of US$26.32 million and diluted EPS of US$0.26, and issued third-quarter guidance calling for revenues of US$1.31 billion to US$1.41 billion and income per share of US$0.43 to US$0.53. Alongside these mixed results, the company pointed to stronger hiring intentions in its U.S. and Canadian surveys, underscoring ongoing demand for specialized talent solutions despite earlier earnings pressure. With...

Hotter, drier UK weather is putting fresh pressure on potato crops and crisp production costs, even as demand for snacks remains steady. That mix of rising input risks and resilient consumer appetite can matter a lot for packaged food stocks in 2026. Some companies may be better placed than others to handle higher irrigation expenses, crop variability and pricing decisions. This article looks at 3 stocks from our Consumer Staples, Packaged Foods & Snacks screener that appear positively...

Charles Schwab stock has delivered a 66.8% return over the past three years, and the current checks suggest the shares may still be pricing in less than the company’s full intrinsic value based on the Excess Returns model. At the same time, traditional earnings multiples point to a level that looks about right rather than deeply discounted. A 66.8% gain over three years puts Charles Schwab in focus for investors asking whether recent strength has already captured most of the...

Investors who take an interest in CVB Financial Corp. ( NASDAQ:CVBF ) should definitely note that the Independent...

We wouldn't blame Tenet Healthcare Corporation ( NYSE:THC ) shareholders if they were a little worried about the fact...

Some BancFirst Corporation ( NASDAQ:BANF ) shareholders may be a little concerned to see that the Non-Executive...

Why New Oriental Education & Technology Group Stock Is Back on Investors’ Radar New Oriental Education & Technology Group (EDU) stock is in focus after the company reported stronger fourth quarter and full year 2026 results, along with fresh revenue guidance for fiscal 2027 and new shareholder return plans. See our latest analysis for New Oriental Education & Technology Group. The latest earnings, fresh revenue guidance and new shareholder returns have put New Oriental Education & Technology...

CBIZ stock has surged in recent weeks and now trades very close to the US$55 per share price implied in Grant Thornton Advisors' agreed all cash acquisition, while the company's broader valuation checks still suggest the shares lean cheap rather than stretched. Over the past 5 years CBIZ has delivered a total return of about 70%, which points to meaningful long term value creation for shareholders compared to shorter term swings. The proposed US$5b all cash takeover by Grant Thornton...

Outlook Therapeutics stock has had a very weak run over the past five years, yet recent FDA approval for its lead drug has put fresh attention on whether the current US$1.00 share price is justified given the broader valuation checks. The share price has declined 97.9% over the past five years, which means long term holders have absorbed very heavy losses that set a low base for any future rerating. The recent FDA approval of LYTENAVA for wet age related macular degeneration can support...

Sunrun stock is trading around US$9.47 after a very steep 82.3% decline over the past 5 years, and the valuation checks send a mixed message about whether that reset has gone far enough. Over 5 years, Sunrun shareholders have seen the share price fall 82.3%. This puts the current valuation in the context of a long and painful reset rather than a short term swing. Future demand for residential solar and Sunrun's ability to turn that demand into steady cash flows can support the current price...